What it's for (Indications)
- Diosmin + hesperidin (micronized purified flavonoid fraction, MPFF), exemplified by Daflon, is a clinically recognized venoactive drug primarily indicated for the treatment of symptoms related to chronic venous insufficiency (CVI).
- This includes alleviation of symptoms such as heavy legs, pain, nocturnal cramps, and edema.
- It is also extensively used for the symptomatic treatment of hemorrhoidal disease, addressing both acute hemorrhoidal attacks and chronic hemorrhoids.
- Its therapeutic efficacy is supported by its action on venous tone, microcirculation, and anti-inflammatory properties, making it a valuable option for managing these vascular conditions and improving patient quality of life.
- The indications are specifically targeted at improving venous return and reducing inflammation and permeability in the vasculature.
Dosage Information
| Type | Guideline |
|---|---|
| Standard | The recommended dosage for diosmin + hesperidin varies depending on the condition being treated. For chronic venous insufficiency, the standard regimen typically involves two tablets daily, each containing 500 mg of MPFF (450 mg diosmin and 50 mg hesperidin), often taken as one tablet at midday and one in the evening with meals. This continuous daily dosing helps maintain therapeutic levels and consistently address symptoms. In the management of acute hemorrhoidal attacks, a higher initial dose is usually prescribed: six tablets per day for the first four days, followed by four tablets per day for the next three days. For chronic hemorrhoids, the dosage is generally two tablets daily. Adherence to the prescribed dosage and duration of treatment is crucial for optimal therapeutic outcomes and symptom management. Always consult a healthcare professional for personalized dosing recommendations. |
Safety & Warnings
Common Side Effects
- Diosmin + hesperidin is generally well-tolerated, with most reported side effects being mild and transient.
- The most commonly observed adverse reactions are gastrointestinal disturbances, which may include nausea, vomiting, diarrhea, dyspepsia, and abdominal pain.
- These effects are typically mild and often resolve without intervention.
- Central nervous system side effects such as headache and dizziness have also been reported, though less frequently.
- In rare instances, hypersensitivity reactions may occur, manifesting as skin rash, pruritus (itching), urticaria (hives), or angioedema.
- Should any severe or persistent side effects occur, discontinuation of the medication and immediate medical consultation are advised.
- It is important for patients to report any unusual symptoms to their healthcare provider.
Serious Warnings
- Black Box Warning: Diosmin + hesperidin (micronized purified flavonoid fraction, MPFF) does not currently carry a formal 'Black Box Warning' as designated by regulatory bodies such as the U.S. Food and Drug Administration (FDA). This type of warning is reserved for medications that have a significantly increased risk of serious or life-threatening adverse effects. However, while there is no official boxed warning, it is crucial for healthcare professionals and patients to be aware of certain important safety considerations and precautions. Patients with known hypersensitivity to diosmin, hesperidin, or any other component of the formulation should strictly avoid its use due to the potential for allergic reactions. Furthermore, in cases of acute hemorrhoidal attacks, this medication provides symptomatic relief but does not replace the need for a thorough proctological examination if symptoms persist or worsen. It is also important to note that for chronic venous insufficiency, this treatment should be considered as an adjunct to, rather than a replacement for, lifestyle modifications and other established therapies like compression therapy. Always consult a healthcare provider for comprehensive guidance and to discuss any pre-existing conditions or potential interactions with other medications.
- While generally safe, several important warnings should be considered when prescribing or taking diosmin + hesperidin.
- This medication does not substitute for lifestyle interventions crucial for chronic venous insufficiency, such as maintaining a healthy weight, avoiding prolonged standing, elevating legs, and wearing compression stockings.
- For acute hemorrhoidal attacks, while providing symptomatic relief, diosmin + hesperidin does not replace specific proctological examinations or therapies; if symptoms persist or worsen, a thorough proctological evaluation is imperative.
- Use during pregnancy should be approached with caution; although clinical studies have not shown adverse effects, administration should only occur if the potential benefits outweigh the potential risks, and under strict medical supervision.
- Due to the lack of sufficient data regarding excretion into breast milk, use during lactation is generally not recommended.
- Patients with a history of hypersensitivity reactions to flavonoids or any excipients should exercise extreme caution or avoid use.
How it Works (Mechanism of Action)
Diosmin + hesperidin, as a micronized purified flavonoid fraction (MPFF), exerts its therapeutic effects through a multifaceted mechanism targeting the venous system and microcirculation. Primarily, it acts as a venotonic agent by increasing venous tone. This is achieved by prolonging the vasoconstrictor effect of noradrenaline on the venous wall, leading to reduced venous distensibility and decreased venous capacitance. Consequently, venous stasis is diminished, and venous return is improved. Secondly, MPFF enhances lymphatic drainage by increasing the frequency and intensity of lymphatic contractions, thereby boosting lymph flow and the number of functional lymphatic capillaries. Thirdly, it significantly improves microcirculation by reducing capillary hyperpermeability and increasing capillary resistance, which helps to mitigate edema and prevent extravasation. Furthermore, it exhibits anti-inflammatory properties by inhibiting the adhesion of leukocytes to the endothelial cells and preventing the activation and migration of inflammatory mediators, thus protecting the microvasculature from inflammatory damage. This comprehensive action profile contributes to its efficacy in managing symptoms of venous disease.
Commercial Brands (Alternatives)
No other brands found for this formula.